RFX-B Antibodies

Santa Cruz Biotechnology provides a broad selection of RFX-B monoclonal antibodies for research focused on understanding RFX-B protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RFX-B is a critical transcription factor involved in the regulation of immune responses and the expression of major histocompatibility complex (MHC) class II genes. Its proper functioning is essential for the development and activation of immune cells, making it a key player in adaptive immunity. Dysregulation of RFX-B can lead to immune deficiencies and has implications in various diseases. Understanding RFX-B's role in immune system regulation continues to be an active area of investigation. Researchers can explore RFX-B's involvement in cellular pathways and disease mechanisms through multiple experimental approaches. Current studies focus on how RFX-B influences immune cell development and function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system regulation and disease mechanisms.